GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Repurchase of Stock

Maxigen Biotech (TPE:1783) Repurchase of Stock : NT$0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech Repurchase of Stock?

Maxigen Biotech's Repurchase of Stock for the three months ended in Mar. 2025 was NT$0.0 Mil.

Maxigen Biotech's Repurchase of Stock for the trailing twelve months (TTM) ended in Mar. 2025 was NT$0.0 Mil.

Maxigen Biotech Repurchase of Stock Historical Data

The historical data trend for Maxigen Biotech's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maxigen Biotech Repurchase of Stock Chart

Maxigen Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Repurchase of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Maxigen Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Repurchase of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Maxigen Biotech Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maxigen Biotech Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Maxigen Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Repurchase of Stock
Comparable Companies
TPE:1752 TPE:4737 ROCO:6499 ROCO:6612 ROCO:6527 ROCO:4116 ROCO:4111 ROCO:6543 ROCO:6730 ROCO:4150 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 88, Keji 1st Road, Guishan District, Taoyuan City, TWN, 333
Website
https://www.mbi.com.tw
Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is mainly engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products. It generates the majority of the revenue from the Biomedical products segment.

Maxigen Biotech Headlines

No Headlines